KYSEF(KYSEF)
KYSEF
No analyst ratings available
No analyst price targets available for KYSEF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $2.33T | $2.34T | $2.40T | $2.35T | $2.36T |
| Low | $2.29T | $2.32T | $2.37T | $2.31T | $2.32T |
| High | $2.37T | $2.36T | $2.43T | $2.37T | $2.39T |
| EBITDA Avg | $742.89B | $746.90B | $765.12B | $747.68B | $751.57B |
| Low | $730.22B | $738.17B | $754.13B | $736.94B | $740.77B |
| High | $754.99B | $752.92B | $774.43B | $756.78B | $760.71B |
| EBIT Avg | $508.73B | $511.48B | $523.95B | $512.01B | $514.67B |
| Low | $500.05B | $505.50B | $516.43B | $504.66B | $507.28B |
| High | $517.02B | $515.60B | $530.33B | $518.25B | $520.94B |
| Net Income Avg | $133.35B | $142.54B | $146.33B | $148.37B | $146.80B |
| Low | $130.86B | $139.88B | $143.59B | $145.60B | $144.06B |
| High | $135.45B | $144.79B | $148.64B | $150.71B | $149.12B |
| EPS Avg | $282.09 | $301.54 | $309.55 | $313.87 | $310.55 |
| Low | $276.82 | $295.91 | $303.77 | $308.01 | $304.76 |
| High | $286.55 | $306.31 | $314.45 | $318.83 | $315.47 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 4 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $649.63B | $562.16B | $594.98B |
| Low | $617.87B | $557.79B | $577.25B |
| High | $681.39B | $566.52B | $612.72B |
| EBITDA Avg | $207.09B | $179.21B | $189.67B |
| Low | $196.96B | $177.82B | $184.02B |
| High | $217.21B | $180.60B | $195.32B |
| EBIT Avg | $141.82B | $122.72B | $129.89B |
| Low | $134.88B | $121.77B | $126.01B |
| High | $148.75B | $123.67B | $133.76B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 2 / — | 2 / — | 1 / — |